Compare Stocks → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:KNETSE:MBX Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKNEKane BiotechC$0.13-3.8%C$0.11C$0.05▼C$0.17C$16.48M0.56152,713 shs150,900 shsMBXMicrobix BiosystemsC$0.34-2.9%C$0.38C$0.23▼C$0.47C$45.74M0.2870,814 shs21,500 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKNEKane Biotech-3.85%0.00%+25.00%+47.06%+4.17%MBXMicrobix Biosystems0.00%-4.29%-10.67%-14.10%-9.46%The Hard Truth About Investing For Retirement (Ad)Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now!MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationKNEKane BiotechN/AN/AN/AN/AN/AN/AN/AN/AMBXMicrobix BiosystemsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceKNEKane BiotechN/AN/AN/AN/AMBXMicrobix Biosystems3.00BuyN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookKNEKane BiotechC$2.74M6.01C$0.01 per share8.50C($0.07) per share-1.79MBXMicrobix BiosystemsC$22.42M2.04C$0.08 per share4.13C$0.20 per share1.68Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateKNEKane Biotech-C$4.32M-C$0.03N/A∞N/A-157.48%N/A-32.70%5/23/2024 (Estimated)MBXMicrobix BiosystemsC$3.72MC$0.0311.17∞N/A16.57%14.66%1.87%5/9/2024 (Estimated)Latest KNE, IMC, and MBX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/26/2024Q4 2023KNEKane BiotechN/A-C$0.01-C$0.01-C$0.01N/AC$0.04 million2/14/2024Q1 2024MBXMicrobix BiosystemsN/AC$0.02+C$0.02C$0.02C$8.10 millionC$8.41 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthKNEKane BiotechN/AN/AN/AN/AN/AMBXMicrobix BiosystemsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioKNEKane Biotech1,164.240.370.39MBXMicrobix Biosystems24.538.535.57OwnershipInstitutional OwnershipCompanyInstitutional OwnershipKNEKane BiotechN/AMBXMicrobix Biosystems0.42%Insider OwnershipCompanyInsider OwnershipKNEKane Biotech36.45%MBXMicrobix Biosystems14.07%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableKNEKane BiotechN/A131.84 millionN/ANot OptionableMBXMicrobix BiosystemsN/A136.55 millionN/ANot OptionableKNE, IMC, and MBX HeadlinesSourceHeadlineMicrobix Presenting at the 2024 Bloom Burton Conferencefinance.yahoo.com - April 11 at 9:13 AMMicrobix Announces Annual and Special Meeting Voting Resultsfinance.yahoo.com - April 1 at 7:42 AMMicrobix’s Clot-Buster Drug Project Advancesfinance.yahoo.com - March 14 at 8:22 AMBo Hollas Sells 100,000 Shares of Microbix Biosystems Inc. (TSE:MBX) Stockinsidertrades.com - March 12 at 5:23 AMMicrobix Biosystems Inc.: Microbix Unveils Test Controls for Head and Neck Cancerfinanznachrichten.de - March 11 at 3:10 PMStocks in play: Microbix Biosystems Inc.ca.finance.yahoo.com - March 11 at 10:10 AMMicrobix Biosystems Inc.wsj.com - March 1 at 4:14 PMMicrobix Announces Issuance of Stock Optionsfinance.yahoo.com - February 26 at 10:35 AMMicrobix Biosystems First Quarter 2024 Earnings: EPS: CA$0.018 (vs CA$0.009 loss in 1Q 2023)finance.yahoo.com - February 17 at 8:26 AMMicrobix Biosystems Inc.: Microbix Reports Record Results for Q1 Fiscal 2024finanznachrichten.de - February 14 at 2:04 PMMicrobix Reports Record Results for Q1 Fiscal 2024finance.yahoo.com - February 14 at 8:57 AMMicrobix Schedules Release of Results for Q1 Fiscal 2024finance.yahoo.com - February 7 at 11:29 AMMicrobix Biosystems Inc.: Microbix Unveils Test Control for Gastric Ulcer Disease Pathogenfinanznachrichten.de - February 6 at 10:26 AMMicrobix Unveils Test Control for Gastric Ulcer Disease Pathogenfinance.yahoo.com - February 6 at 10:26 AMMicrobix Achieves Further QAPs Sales Recordfinance.yahoo.com - January 3 at 11:20 AMMicrobix Biosystems Full Year 2023 Earnings: Revenues Miss Expectationsfinance.yahoo.com - December 22 at 10:06 AMMicrobix Reports Results for Q4 & Full-Year Fiscal 2023finance.yahoo.com - December 21 at 8:11 AMMicrobix & Seegene USA Jointly Enhancing Lab Test Accuracyfinance.yahoo.com - December 14 at 10:24 AMMicrobix & BioGX Collaborate on real-time PCR Assays & Controlsfinance.yahoo.com - December 7 at 8:19 AMMicrobix Presenting at Florida Capital Event Conferencefinancialpost.com - November 17 at 7:13 AMMicrobix Biosystems Inc.: Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Marketfinanznachrichten.de - November 16 at 8:06 AMMicrobix Clot-Buster Drug Fully-Funded For Return to U.S. Marketfinance.yahoo.com - November 16 at 8:06 AMMicrobix & Ulisse Biomed Collaborate on HPV Controls & Assaysfinance.yahoo.com - November 10 at 9:19 AMMicrobix QAPs Supporting HPV Testing in Irelandfinance.yahoo.com - October 27 at 8:16 AMMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioPVH Stock Gets 25% Discount: Is Now the Time to Buy?April 2, 2024 11:25 AMView PVH Stock Gets 25% Discount: Is Now the Time to Buy?It’s Time to Buy Into the Super Micro Computer Stock ImplosionApril 22, 2024 12:33 PMView It’s Time to Buy Into the Super Micro Computer Stock Implosion2 Stocks to Buy on The Dip: One a Value, the Other High-YieldingApril 12, 2024 7:32 AMView 2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding6 Mortgage REITS: How Badly Could Rising Rates Hurt Them?April 3, 2024 7:12 AMView 6 Mortgage REITS: How Badly Could Rising Rates Hurt Them?All Headlines Company DescriptionsKane BiotechCVE:KNEKane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.Microbix BiosystemsTSE:MBXMicrobix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
